Abstract The Ly5.1 mouse, also termed B6.SJL-Ptprc a Pepc b /BoyJ, is a congenic strain widely used as a recipient in animal studies of bone marrow transplant. Our previous study documented that a majority of type I spiral ganglion neurons (SGNs) in the apical turns of Ly5.1 mice are unmyelinated and aggregate into neuronal clusters, similar to the spiral ganglion in the human ear. Ouabain, a well known Na-K ATPase inhibitor, has been shown to induce neuronal degeneration in a variety of neural tissues including the adult gerbil and CBA/CaJ mouse spiral ganglion. Here, functional and pathological changes of the auditory nerves in young-adult Ly5.1 mice were examined at 3, 7 and 14 days after ouabain exposure. Similar to observations in CBA/CaJ mice, ouabain application selectively removed type I SGNs, resulting in an immense decline of the auditory nerve function. Hyperplasia of glial cells was seen in the injured auditory nerves at 7 days after ouabain exposure. Our data indicate that the "human-like"features of unmyelinated type I SGNs have no protective impact on the fate of SGNs after ouabain exposure. Cells incorporating bromodeoxyuridine (BrdU) and expressing Sox2 were also counted in the auditory nerves of control and ouabain-treated ears. The number of Sox2 + glial cells significantly increased at 3 and 7 days post-treatment. Interestingly, the highest density of BrdU + cells appeared in the apical turn of the injured auditory nerve shortly after ouabain exposure, suggesting that the pattern of SGN loss at the apical turn in Ly5.1 mouse may have some impact on the reaction of non-neuronal cells in response to acute ototoxic drug exposure in the auditory nerve.
Introduction
Spiral ganglion neurons (SGNs) and their processes (afferent auditory nerves) are the primary carriers that delivery auditory information from the sensory hair cells of the inner ear to the central nervous system. There are two subclasses of SGNs and afferent auditory nerve fibers: type I and type II. 1, 2 Type I afferent nerve fibers synapse inner hair cells and are all myelinated. In contrast, type II nerve fibers are unmyelinated and innervate the outer hair cells. In most mammalian spe• cies, type I SGN cell body is also heavily myelinated, which represents about 90-95% of SGNs. The remaining type II neurons are unmyelinated and located primarily in the periphery of the spiral ganglion. How• ever, in the human inner ear, type I SGNs are mostly unmyelinated . 3, 4, 5, 6 The functional basis of this ana• tomical difference in spiral ganglion between human and other mammalian species is still unclear.
The Ly5.1 mouse, also termed B6.SJL-Ptprc a Pepc b / BoyJ, is a congenic strain widely used as a recipient in animal studies of bone marrow transplant . 7, 8 The Ly5 gene includes allelic forms Ly5.1 and Ly5.2. This difference allows the identification and differentia• tion of the donor Ly5.2 cells from recipient Ly5.1cells using immunofluorescent staining and flow cytometry. In a previous study, we found that a majority of type I SGNs in the apical turns of Ly5.1 mice were unmyelin• ated and mostly aggregated into neuronal clusters, which have a high level of similarity to human spiral ganglion (8) . This mouse strain provides a unique ani• mal model for studying human auditory nerve function as well as pathological changes of the human spiral gan• glion with aging, neurodegenerative diseases and expo• sure to ototoxic drugs.
Ouabain was originally isolated from the ripe seeds of the African plant strophanthus gratus and the bark of Acokanthera ouabaio. It is a well-known Na, K-ATPase blocker and was widely used in vitro studies to specifically inhibit the sodium pumps in a variety of cell types including neurons . 9 Application of ouabain to the round window of young-adult gerbils 10, 27 and CBA/CaJ mice 11 induced a selective loss of type I SGNs by apoptotic-like degeneration. In addition, we also found an upregulation of Sox2 transcription factor and increased glial cell proliferation in the spiral gan• glion of young-adult CBA/CaJ mice shortly after oua• bain exposure. 11 In this study, we examined if 1) the 'human-like features'of the spiral ganglion in Ly5.1 mice protect SGN from degeneration secondary to oua• bain ototoxicity; and 2) glial cell proliferation and Sox2 upregulation occur differently in Ly5.1 mice as com• pared to those in CBA/CaJ mice after ouabain expo• sure. /BoyJ (Ly5.1) mice were bred in-house with original breeding pairs purchased from The Jackson Laboratory (Bar Harbor, ME, see database for Ly5.1 mice at http://jaxmice.jax.org/strain/002014. html, Stock# 002014) and raised in a low-noise envi• ronment at the Animal Research Facility of the Medical University of South Carolina. CBA/CaJ and C57BL/6J mice purchased from The Jackson Laboratory were used as the controls in the morphological observations. All mice received food and water ad libitum and were maintained on a 12-hour light/dark cycle. Mice of both genders aged 1 to 3 months (weighing 16-25g ) were used in the study. Throughout the paper, the term "young adult mice" applies to all of the 4 to 12 week-old mice. All aspects of the animal research were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee of the Medical University of South Carolina. Prior to data acquisition, mice were examined for signs of external ear canal and middle ear obstruction. Mice with any symptoms of ear infection were excluded from the study. Ly5.1 mice were administered daily intra-peritoneal doses of bromodeoxyuridine (BrdU, 100 mg/kg, Sigma) for five days including the day preceding ouabain treat• ment, the day of ouabain treatment, and the three days following ouabain treatment. BrdU incorporation analy• sis was processed at 3,7 and 14 days after ouabain treat• ment.
Materials and Methods

Animals
Physiological procedures
Mice were anesthetized by an intraperitoneal injec• tion of xylazine (20mg/kg) and ketamine (100mg/kg) and placed in a head holder in a sound-isolation room. Young adult Ly5.1 mice were used for physiological measurements before and after ouabain treatment. Auditory brainstem responses (ABRs) were recorded via customized needle electrodes inserted at the vertex (+ ) and test-side mastoid (-), with a ground in the control-side leg. The acoustic stimuli were generated using Tucker Davis Technologies equipment III (Tuck• er-Davis Technologies, Gainesville, FL, USA) and a SigGen software package. The calibration was completed using a Knowles microphone in a probe tube clipped to the pinna. The signals were delivered into the mouse ear canal through a 10 mm long (3-5 mm diameter) plastic tube. ABR thresholds, defined as the lowest sound levels at which the response peaks are clearly present as read by the eye from stacked wave forms, were obtained. ABRs were evoked at half octave fre• quencies from 4 to 45 kHz with 5 ms duration tone pips with cos 2 rise/fall times of 0.5 ms delivered at 31/s. Sound levels were reduced in 5-dB steps from 90 dB SPL to 10 dB SPL below thresholds. At each sound level, 300-500 responses were averaged, using an"artifact reject"whereby response waves were discarded when peak to peak amplitude exceeded 50 mV. Physiological results were analyzed for individual frequencies, and then averaged for each of these frequencies from 4.0 to 40 kHz.
Surgical procedures
Surgical approach employed to expose the round win• dow of the Ly5.1 mouse was modified slightly from a previous description (11, 12) . The cochlea was exposed through a post-auricular approach and a small perfora• tion was created to expose the round window niche. About 5 μl ouabain solution (1 mM in normal saline) was applied to the round window, filling the niche com• pletely, using a 26 gauge needle and tuberculin syringe under direct microscopic guidance. The total time of ouabain exposure was 45-60 minutes, during which ouabain was applied every 10 minutes. The right ear was the operative ear while the left ear served as a con• trol. The mice were allowed to recover for 3, 7 and 14 days after ouabain exposure. Note that ouabain treated mice showing no ABR threshold shift or a threshold shift less than 20 dB SPL were excluded from further study.
Morphological and immunohistochemical analysis
Young adult mice were used for the following proce• dures including morphological and immunohistochemi• cal analysis. For morphological observation, the anes• thetized animals were perfused via cardiac catheter first with 10 ml of normal saline containing 0.1 % sodi• um nitrite and then 15 ml of a mixture of 4% parafor• maldehyde and 2% glutaraldehyde in 0.1M phosphate buffer, pH 7.4. After removing the stapes and open• ing the oval and round windows, 0.5 ml of fixative was perfused gently into the scala vestibuli through the oval window. The inner ears were dissected free and immersed in fixative overnight at 4°C. Decalcification was completed by immersion in about 50 ml of 120 mM solution of ethylenediamine tetracetic acid (EDTA), pH 7.2, with gentle stirring at room temperature for 2-3 days with daily changes of the EDTA solution. The tis• sues were postfixed with a 1% osmium tetroxide for 1 hour, dehydrated and embedded in Epon LX 112 resin. Semi-thin sections approximately 1 mm thick were cut and stained with toluidine blue.
For immunohistochemistry, the inner ears were pre• pared following the procedure described above but sub• stituting 4 % paraformaldehyde as fixative, decalcified with EDTA, cryprotected in 30 % sucrose in PBS and embedded in Tissue-Tek OCT compound (Electron Mi• croscopy Science, FT. Washington, PA). For BrdU staining, additional pre-treatment for frozen tissue sections was included as follows: the sections were denatured with 2N HCl in 0.05% Tween-20 in PBS, pH7.4 for 30 min at 37°C, and neutralized in 0.1 M sodium borate pH 8.5 for 10 min.
Frozen sections or surface preparations of cochlear tissue were incubated overnight at 4°C with a primary antibody diluted in PBS. The primary antibodies used in this study were mouse anti-BrdU (1:1000, B2531, Sigma, Atlanta, GA), mouse anti-neurofilament 200 (1: 200, Clone N52, N0142; Sigma, Atlanta, GA), mouse anti-connexin 43 (1:200, Clone N52, 13-8300; Zymed Labs, Carlsbad, CA), goat anti-Sox2 (1:200, sc17320, Santa Cruz Biotechnology, Santa Cruz, CA) and rabbit anti-Sox2 (1:500, AB5603, Chemicon, Temecula, CA).
For double staining protocols, the primary antibodies selected were generated in different species (e.g., one mouse monoclonal antibody with one rabbit or goat polyclonal antibody). Note that the antibodies gener• ated in either host gave the same immunolabeling patterns. The mouse monoclonal anti-BrdU was produced by clone BU33 and raised against BrdU incorporated into DNA or coupled to a protein carrier. It recognized proliferative cells in the nuclei of frozen and paraf• fin-embedded tissue sections of animals treated with an in vivo administration of BrdU (manufacturer's technical information). In this study, we verified that the antibody does not reveal staining in ouabain-treat• ed auditory nerves without BrdU administration.
The goat polyclonal antibody to Sox2 was raised against a peptide corresponding to C-terminus aa 227-293 of human origin (manufacturer's technical information). Using this antibody, previous studies have shown that Sox2 is expressed in the nuclei of the multipotent progenitor cells in mouse eye 13 and in the · ·21 specific neural progenitor cells in the postnatal hippo• campal subventricular zone. 14 The rabbit polyclonal an• tibody to Sox2 was generated against a synthetic pep• tide from human Sox2 (Acc# P448431, manufacturer' s technical information). Both antibodies reveal simi• lar staining patterns in the mouse inner ear. Previ• ous immunocytochemistry studies demonstrated that Sox2 is highly expressed in all prosensory and sensory epithelia of the developing mouse inner ear, 15 the nu• clei of the supporting cells in both auditory and vestibu• lar organs of the adult mouse ear, 16 and in the nuclei of Schwann cells in the developing chicken cochleovestib• ular ganglion . 17 The mouse monoclonal antibody to neurofilament 200 (phosphorylated and non-phosphorylated, clone N52) reacts with the neurofilament of molecular weight 200 kDa in rat spinal cord extracts (manufacturer's technical information). When tested by immunoblotting on pig neurofilament polypeptides, the antibody reacts with an epitope in the tail domain of neurofilament 200, also referred to as the H-subunit, which is present on both the phosphorylated and non-phosphorylated forms of this polypeptide. The staining patterns with neurofil• ament 200 in the mouse auditory nerve here were simi• lar to those in previous reports. [18] [19] [20] [21] [22] The mouse monoclonal anti-connexin 43 was gener• ated against a synthetic peptide that corresponds to a cytoplasmic sequence located near the C-terminus of rat connexin 43 and is specific for the unphosphorylated form of connexin 43. 22 The activity of this antibody has been confirmed by Western blotting in protein extracts from mouse and rat brain, mouse, dog and human heart and C1-9 rat liver cells (manufacturer' s technical infor• mation). Previous studies using this antibody indicated that connexin 43 is expressed preferentially by glial cells in the central nervous system and by satellite cells in the trigeminal ganglion. 23 Quantitative analysis of BrdU-and Sox2-expressing cells was performed using cochleas from three to five young adult mice of each group. Cell count data were collected from five to six 15μm mid-modiolar frozen sections per cochlea. The values of the sampling area and numbers of BrdU-and Sox2-expressing cells were determined and collected using the Automatic Measure• ment Feature of AxioVison 4.8 software (Carl Zeiss Inc., Jena, Germany). The sections used for counting were at least 30 μm apart (e.g., cell counting was per• formed on 1 in every 3 serial sections). Confirmation of double-labeling Sox2 with BrdU was performed by focusing through the full height of the section.
The sections were examined either with a Zeiss Axio Observer or a Zeiss LSM5 Pascal confocal microscope (Carl Zeiss Inc., Jena, Germany). The captured images were processed using Image Pro Plus software (Media Cybernetics, MD), AxioVison 4.8 (Carl Zeiss Inc., Jena, Germany) and Zeiss LSM Image Browser Version 2,0, 70 (Carl Zeiss Inc., Jena, Germany). Adobe Photoshop CS2 was employed to adjust brightness, contrast, and sharpness of images with identical setting for all panels.
Alterations were not performed on images used for quantitative purposes.
Data analysis
Unless otherwise specified, all data in the figures are presented as mean ± standard error of the mean (SEM). Data for the ABR thresholds, the density of Sox2 
Results
Expression patterns of NF 200 and connexin 43 in normal auditory nerve
Neurofilament 200 (NF200) antibody stained interme• diate filaments of neuronal cells, which provide support for normal axonal radial growth. NF 200 is a widely used neural marker for both type I and type II SGNs (18, 19, 20, 24) . As shown in Figure 1 , all SGNs in CBA/ CaJ, C57BL/6J and Ly5.1 mice were stained positively for NF200. A large number of SGNs in the apical and middle turns of normal young-adult Ly5.1 mice lacked myelin sheaths around their cell bodies resulting in a unique staining pattern with clustering NF200 + neurons (Fig. 1C) . In contrast, NF200 + SGNs in CBA/CaJ and C57BL/6J mouse ears were ensheathed with connexin 43 + myelinated sheaths, forming a honey-comb-like staining pattern (Figs. 1A,B) .
Connexin 43 is expressed by glial cells in both the central and peripheral nervous system. 23 Our data are the first to demonstrate that connexin 43 is expressed · ·22 by myelin sheaths and Schwann cells in the mouse audi• tory nerve including CBA/CaJ, C57BL/6J and Ly5.1 strains (Fig. 1) . A lack of connexin 43 expression with• in neural aggregates further validated the deficiency of Schwann cell processes in the Ly5.1mouse spiral gangli• on. Connexin 43 expression remained positive in almost all nerve processes within the osseous spiral lamina in the Ly5.1 mouse ear (Fig. 1D) .
Decline of auditory nerve function and type I SGN degeneration after ouabain exposure
Ouabain applied to the round window of young adult Ly5.1 mice induced a severe decline of auditory nerve function within a few days (Fig. 2) . Auditory brainstem re• sponse (ABR) wave I thresholds were markedly elevated across all frequencies at 3, 7 and 14 days post-expo• sure. There is no statistical difference in ABR wave I thresholds across all frequencies among the three post-exposure groups (unpaired t-test, p>0.05), indicat• ing permanent threshold shifts in ABR wave I occurred as early as 3 days post-exposure. Figure 3 illustrated pathological changes of the spiral ganglia within Rosenthal' s canal in the apical, middle and basal turns. In the contralateral control ears, the unmyelinated type I neuron clusters were seen mostly in the apical and also occasionally in the middle turns of Ly5.1 mice (Fig. 3A,B) , similar to our previous obser• vations in this mouse strain 8 . By 7 days after ouabain exposure, all these neuronal clusters disappeared. A small number of surviving SGNs were often seen in the periphery of the spiral ganglion across all three turns. In addition, most myelinated auditory fibers disap• peared in the osseous spiral lamina (Figs. 4A,C) and modiolus where the glial transition zone is located (Figs. 4C,D) . Hyperplasia of glial cells was also seen in the injured auditory nerve within these two areas, indi• cating the activation of glial cells occurs both in Schwann cells and oligodendrocytes. A large num• ber of spindle-shaped glial cells were seen within most areas of Rosenthal' s canal in the apical turn and lateral portions of Rosenthal' s canal in the middle and basal turns (Figs. 3D-F) . Figure 2 Auditory nerve function decline in ouabain-treated young-adult Ly5.1 mice. ABRs to pure tones were recorded at 3 (n=7), 7 (n=8) and 14 (n=6) days after ouabain exposure. The da• ta were plotted as mean ABR thresholds before and after treat• ment. Three days after ouabain treatment ABR thresholds were markedly increased at all tested frequencies; ABR thresholds con• tinued to increase at 7 days and 14 days after treatment. To further identify the cellular and molecular charac• teristics of these activated glial cells, dual-immunos• taining for Sox2 and BrdU was performed in the Ly5.1 mouse ears at 3, 7 and 14 days after ouabain exposure (Figs. 5-7) . The transcription factor Sox2 + is predomi• nantly expressed in undifferentiated neural cells during development and adult neurogenesis after injury. 25, 26 In the contralateral normal ear, a few of Sox2 + cells were seen in Rosenthal' s canal across all turns (Figs. 5A,C) . In contrast, little or no staining of Sox2 The use of BrdU incorporation assays revealed that very few cells were mitotic in the normal auditory nerve (Figs. 5A,C) . These results agree with our previous observations in normal adult gerbil and CBA/CaJ mice. 11, 27 The proliferative cells in the normal Ly5.1 mouse ears are most likely non-neuronal cells such as glial cells, fibroblasts, vascular endothelial cells or microgli• al cells based on the morphological characteristics of their nuclei. Following ouabain exposure, the number of BrdU + cells was significantly increased 3, 7 and 14 days after ouabain treatment (ANOVA, p<0.05) (Fig.  7B) . In particular, the highest density in BrdU 
Dissussion
In our previous study, we have indicated that the spi• ral ganglion of the young-adult Ly5.1 mouse has a high degree of"human-like features"such as unmyelinated type I SGNs and aggregated neural clusters in the api• cal and middle turns 8 . Within these clusters, type I SGNs are in direct somato-somatic apposition, with no intervention with Schwann cells or neural processes.
These unique morphological characteristics in Ly5.1 mouse may have some impact on the fate of SGNs and other cells of the auditory nerve in response to ouabain exposure.
Here, we have described the auditory functional de• clines and pathological changes of SGNs and their pro• cesses in the young-adult Ly5.1 mice after ouabain ex• posure. Similar to our previous studies in the young adult gerbil and CBA/CaJ mice 10, 11, 27 , ouabain can selec• · ·26 tively induce the degeneration of type I SGNs in the young adult Ly5.1 mouse. Permanent ABR threshold shifts across all tested frequencies were seen as early as three day after ouabain exposure. A majority of SGNs, including these neural clusters in the apical and middle turns, disappeared by 7 days after ouabain exposure. These results demonstrate that "human-like features" of unmyelinated type I SGNs have no any protective impact at all on the fate of SGNs after ouabain exposure, at least for the administrated protocol we estab• lished . 11, 27 Our study also demonstrates that 1) Sox2 is expressed in a subset of glial cells in the auditory nerve of the adult Ly5.1 mouse glial cells and 2) the adult spiral ganglion undergoes hyperplasia shortly following oua• bain exposure as previously observed in young-adult CBA/CaJ mice 27 . Interestingly, we found two different characteristics in the pathological changes of Ly5.1 mouse spiral ganglion after ouabain exposure as com• pared to those in the CBA/CaJ mouse: 1) the highest den• sity of BrdU + cells appeared in the apical turn of injured auditory nerve 3 days after ouabain exposure; and 2) the number of Sox2 + /BrdU + cells in the basal auditory nerve was lower than those in the apical and middle turns at 7 and 14 days after ouabain exposure.
The high proliferative rate in non-neuronal cells of the apical turn after ouabain exposure may be associated with the"human-like"features of unmyelinated type I SGNs in young-adult Ly5.1 mice. Within neural clus• ters of the Ly 5.1 mouse spiral ganglion, junction-like symmetrical structures appeared on adjoining plasma membranes of neighboring neurons . 8 These specialized junction-like structures may be the structural basis of direct neuron-to-neuron communication, allowing each neuronal cluster to act as a"functional unit"in both physiological and pathological conditions including neuronal degeneration in response to ouabain expo• sure . 28 A large number of SGNs dying simultaneously within a short period may result in a unique injury microenvironment, which is more favorable for the de-differentiation and proliferation of glial cells and/or other non-neuronal cells in the auditory nerve.
Another interesting finding is that the number of Sox2 + /BrdU + in the basal auditory nerve was lower than those in the apical and middle turns at 7 and 14 days after ouabain exposure. A subpopulation of glial cells up-regulate Sox2 gene and proliferate after injury sug• gest quiescent glial cells are able to revert to more un• differentiated states. 29, 30, 31 In fact, a certain level of neu• ronal SGN degeneration was seen in the basal turns of normal young-adult Ly5.1 mice 8 This chronic neuronal degeneration may be an extrinsic factor that contributes to the declined ability of glial cell proliferation or dedif• ferentiation in the basal turn of young adult Ly5.1 mice.
